Skip to main content
PMC home page
Regenerative Biomaterials logoLink to Regenerative Biomaterials
. 2019 Sep 30;7(1):9–17. doi: 10.1093/rb/rbz030

Inhibition of the negative effect of high glucose on osteogenic differentiation of bone marrow stromal cells by silicon ions from calcium silicate bioceramics

Xixi Dong 1,#, Xiaoya Wang 2,#, Min Xing 2, Cancan Zhao 2, Bin Guo 1, Junkai Cao 1,✉, Jiang Chang 2,✉
PMCID: PMC7233608  PMID: 32440357

Abstract

Human bone marrow stem cells (hBMSCs) are exploited for miscellaneous applications in bone tissue engineering where they are mainly used as seed cells. However, high glucose (HG) environment has negative impacts on the proliferation and osteogenic differentiation of hBMSCs, thus reducing the bone formation in diabetic patients. In our former research works, we discovered that silicon (Si) ions extracted from silicate-based bioceramics are able to stimulate the proliferation and osteogenic differentiation of hBMSCs under normal culture condition. This study aimed to investigate if Si ions could prevent HG-induced inhibition of proliferation and osteogenesis of hBMSCs. We found that 2.59 ppm concentration of Si ions promoted the proliferation of hBMSCs under HG condition. The results from alkaline phosphatase (ALP) activity assay, Alizarin red S staining and quantitative real-time PCR analysis of osteogenic genes (BMP2, RUNX2, ALP, COL1 and OCN) demonstrated that the 15.92 ppm concentration of Si ions prevented HG-induced inhibition of the osteogenic differentiation of hBMSCs. Moreover, application of Si ions reduced the level of reactive oxygen species in HG-treated hBMSCs. In HG-treated hBMSCs following 15.92 ppm Si ions treatment, activation of BMP2/SMAD signaling pathway was detected, as indicated by the increased expression of BMP2 receptors and its downstream genes such as SMAD1, SMAD4 and SMAD5. Taken together, we provide evidence that the specific concentration of Si ions compensated HG-induced inhibition of proliferation and osteogenic differentiation of hBMSCs through antioxidant effect and modulation of BMP2/SMAD pathway. The results suggest that silicate-based bioceramics might be good scaffold biomaterials for bone engineering applications in diabetes patients.

Keywords: high glucose, silicate, osteogenic differentiation, bone tissue engineering

Introduction

Clinical osseous insufficiency is described as a gap in bone integrity and is initiated by factors such as inherited defect, pain or operating resection [1]. The advances in bone tissue engineering have boosted the development of alternative approaches for the repair and reconstruction of bone defects. Seed cells and scaffolds are considered as the two important factors in bone tissue engineering. However, human bone marrow stem cells (hBMSCs), one of the most important seed cells with multiple differentiation ability [2], has enormous challenges in bone tissue engineering under high glucose (HG) condition.

Growing number of studies indicate that hyperglycemia impairs bone quality, though the underlying mechanisms remain unclear. In vitro experiment has proven that HG microenvironment exerts a consequential inhibitory action on the osteogenic differentiation and growth of hBMSCs [3, 4] and MC3T3-E1 cells [5], indicating that the negative effect of HG condition on hBMSCs might be closely related to the diabetes associated decrease of bone regeneration ability. Previous publications conveyed that HG hinders the osteogenic differentiation of BMSCs via modulating the BMP signaling pathway which downregulates the levels of osteogenic markers such as osteocalcin, alkaline phosphatase (ALP) and Runx2 [6]. In addition, it was demonstrated that, under HG condition, Runx2 induces matrix mineralization by upregulating the expression levels of osteogenic markers [7]. Furthermore, premature aging, genomic instability and telomere changes were detected in HG-treated BMSCs, which led to decreased rate of BMSCs proliferation [8].

Silicate bioceramics have been found to stimulate bone regeneration and are considered as promising scaffold materials for bone tissue engineering. Our previous studies have shown that silicate bioceramics had good biocompatibility, safety and osteoconductivity [9, 10], and Si ions released from silicate-based bioceramics pointedly enhanced the osteogenesis and growth of BMSCs, and stimulated angiogenesis of endothelial cells [11–14]. Our recent study has demonstrated that the Si ions in the concentrations of 2.59 and 15.92 ppm stimulated the proliferation and osteogenic differentiation of hBMSCs, respectively [15]. And it is reported that 30 mM glucose can inhibit the proliferation and differentiation of BMSCs [4]. Therefore, our hypothesis is that Si ions from silicate-based bioceramics may be also effective in compensating the adverse impact of high levels of glucose on the osteogenesis of hBMSCs.

This study aimed to investigate whether the Si ions extracted from calcium silicate (CS) could alleviate or compensate the inhibitory action of high levels of glucose on the proliferation and osteogenesis of hBMSCs. The possible mechanisms related to the effect of Si ions on hBMSCs under HG condition, in particular the effect on osteogenic signaling pathways such as the BMP2 signaling pathway was also investigated.

Materials and methods

Preparation of biomaterial extracts

CS powders were obtained as previously described chemical co-precipitation approach [16]. Briefly, the CS powder was soaked in 200 mg/ml of basal medium for human mesenchymal stem cells (Cyagen Biosciences, USA). Following the incubation at 37°C for 24 h in an incubator containing 5% CO2, the mixture was centrifuged at 2000 g at room temperature for 10 min. Then, the supernatant was collected and filtered through a microfilter (Millipore, 0.22 mm) before storage at 4°C according to the ISO10993-1 standard [17]. The content of Si ions in the extracts was determined by inductively coupled plasma optical emission spectroscopy (710-ES, Varian, USA) [15].

Cell culture

The hBMSCs were purchased from Cyagen Biosciences Inc. (USA) and seeded using the basal medium for human mesenchymal stem cells (Cyagen Biosciences, USA) added with glutamine (Cyagen Biosciences, USA), 10% hBMSCs-specific FBS (Cyagen Biosciences, USA), 100 mg/ml streptomycin and 100 U/ml penicillin (Cyagen Biosciences, USA). The culture protocol was performed in an incubator following the method described in our previous work [18]. Since our previous study showed that 2.59 and 15.92 ppm optimal concentrations of Si ions in the medium, respectively, enhance the proliferation and osteogenic differentiation of hBMSCs [15], we selected the Si ions concentrations of 2.59 and 15.92 ppm for cells proliferation and osteogenic differentiation experiments, separately.

Cell proliferation assay

The proliferation assay was performed to determine the effect of Si ions on proliferation of hBMSCs under HG condition. The hBMSCs (1 × 103 cells/well) were seeded in 96-well plates and cultured in a humidified 5% CO2 incubator at 37°C. Cells were cultured in different medium: normal glucose (NG) 5.5 mM, 5.5 mM + 2.59 ppm (NG + 2.59), high glucose (HG) 30 mM and 30 mM + 2.59 ppm (HG + 2.59). After culturing for 1, 3 and 7 days, the Cell Counting Kit (CCK-8) assay kit (Beyotime) was applied to detect the viability of hBMSCs following the manufacturer recommendations. Briefly, at each time point, the culture medium was replaced by the fresh medium added with the CCK-8 reagent (10:1) and the cells further incubated in the same culture condition for additional 2 h. Finally, the ELX Ultra Microplate Reader (Bio-tek, USA) was used to spectrophotometrically measure the optical density (OD) at 450 nm. The results were expressed as units of OD absorbance value.

ALP assay

ALP staining was performed 10 days after culture in 24-well at a density of 1 × 105 cells/well according to a previously protocol [19]. Briefly, after washing with 1 × PBS, cells were fixed for 15 min in 4% paraformaldehyde at room temperature. Next, the cells were washed using the deionized water and subsequently incubated in 166 ml/4 ml naphthol/fast blue solution (Sigma) in the dark for 20 min at 37°C following the manufacturer’s protocols. The stained cells were subsequently examined using the Leica microscope coupled with a digital camera (DMI 3000) and photographed.

The ALP Assay Kit (Colorimetric, Abcam, UK) was also used to measure ALP activity. In brief, cell lysates were harvested and after centrifugation (10 000 rpm) for 10 min at 4°C, the Pierces BCA Protein Assay Kit (Thermo ScientificTM, USA) was employed to determine the total protein concentration [18]. Next, the supernatant was aliquoted (100 μl) and combined with 200 μl p-nitrophenyl-phosphate solution (pNPP: Sigma, St. Louis, USA) in a 96-well plate. Finally, the Microplate Reader (Bio-tek, USA) was used to measure the absorbance at 405 nm which was used to calculate ALP activity. The concentration of cell total protein was used for normalization.

Alizarin red S staining

Cells (1 × 105 cells/well) were cultured in triplicate in diverse media for 21 days in 24-well plates. Culture media were added with b-glycerophosphate (10 mM), dexamethasone (100 nM) and ascorbic acid (0.05 mg/ml). Alizarin red S staining was carried out as described in a previous paper [20]. Briefly, after rinsing twice with PBS, cells were fixed for 10 min in 10% formalin at room temperature. Subsequently, the cells were washed several times using distilled H2O and stained by 2% (w/v) Alizarin red (Sigma) for 5 min at room temperature. After staining, the cells were washed before imaging under microscope.

Detection of reactive oxygen species

For the detection of the intracellular reactive oxygen species (ROS), cells (1 × 105 cells/well) were cultured in triplicate using the 24-well plates. Following cell attachment, the medium was refreshed with NG (5.5 mM), NG + 16 (5.5 mM + 16ppm), HG (30 mM) or HG + 16 (30 mM + 16ppm) medium and further cultured for 24 h. ROS level was detected by the 2,7-dichlorofluorescein diacetate (DCFH-DA) fluorescent kit (Beyotime Institute of Biotechnology, China) [5]. Briefly, after adding 10 μM of DCFH-DA and incubation in the dark at 37°C for 20 min, cells were washed twice using the serum-free medium. The excitation at 488 nm and the emission at 525 nm were recorded by the microplate reader (Synergy HTX, Bio-tek Instruments Inc., Winooski, VT, USA). Finally, the ROS level was calculated as the ratio of OD488 to OD525.

Quantitative real-time PCR assay

Cells (2 × 105 cells/well) were cultured for 3 days in 6-well plates. The Trizol reagent (Invitrogen, USA) was employed for the extraction of total RNA. After reverse-transcription to cDNA as previously described [21], quantitative real-time PCR (qRT-PCR) amplification reaction was achieved on the Ex Taq DNA polymerase (TaKaRa, China). The primers used for the amplification were listed in Table 1. GAPDH was employed as the endogenous gene for normalization. The experiments were done in triplicate. The mRNA level was presented as 2-ΔΔCt and normalized to the controls.

Table 1.

The sequences of the primers for qPCR in the experiment

Gene Forward primer Reverse primer
ALP 5′ACCACCACGAGAGTGAACCA 5′CGTTGTCTGAGTACCAGTCCC
RUNX2 5′TGGTTACTGTCATGGCGGGTA 5′TCTCAGATCGTTGAACCTTGCTA
BMP2 5′TTCGGCCTGAAACAGAGACC 5′CCTGAGTGCCTGCGATACAG
COL1 5′GAGGGCCAAGACGAAGACATC 5′CAGATCACGTCATCGCACAAC
OCN 5′CACTCCTCGCCCTATTGGC 5′CCCTCCTGCTTGGACACAAAG
BMPR1A 5′CCTGGGCCTTGCTGTTAAATTCA 5′TCCACGATCCCTCCTGTGAT
BMPR1B 5′GTTGCTACTGGCTGTTTTGG 5′AAGTTCCCTGGGTGTCTG
BMPR2 5′GGCAGCAGTATACAGATAGGTG 5′CTGCCCTGTTACTGCCATTATT
SMAD1 5′GTATGAGCTTTGTGAAGGGC 5′TAAGAACTTTATCCAGCCACTGG
SMAD4 5′CTCCAGCTATCAGTCTGTCA 5′CCCGGTGTAAGTGAATTTCAAT
SMAD5 5′TCATCATGGCTTTCATCCCACC 5′GCTCCCCAACCCTTGACAAA
GAPDH 5′-TTCGACAGTCAGCCGCATCTT-3′ 5′-ATCCGTTGACTCCGACCTTCA-3′
Open in a new tab

Statistical analysis

All the data were expressed as mean ± standard deviation. The student’s t-test was used to evaluate the inter-group differences. The number of parallel samples is three in each cell assay. The difference was deemed statistically significant at a P values cutoff of < 0.05.

Results

The effect of Si ions on cell viability in HG-treated hBMSCs

In order to determine whether Si ions affect the proliferation of hBMSCs under HG condition, Si ions were added into the HG medium with the final concentration of 2.59 ppm. Results depicted in Fig. 1 indicated that cell proliferation in NG + 2.59 was promoted compared with the cells in NG alone at day 7, while decreased proliferation of cells in HG was detected as compared with the cells in NG at day 3 and day 7. Notably, the proliferation of cells in HG + 2.59 did not show significant difference as compared with cells in NG alone and HG alone at day 1 and day 3, whereas significantly higher proliferation was observed at day 7 as compared with the cells in HG alone. The results confirmed that HG-inhibited proliferation of hBMSCs, and the treatment of 2.59 ppm Si ions indeed compensated the inhibition of cell proliferation caused by HG.

Figure 1.

Figure 1

Open in a new tab

Effects of HG and Si on the proliferation of cultured hBMSCs. The data are represented as mean ± S.D. *P < 0.05 and **P < 0.01 compared with NG control group. #P < 0.05 compared with HG group. Si, silicon ion; NG, normal glucose; HG, high glucose; Si 2.59ppm represents the concentration of Si ions in medium

The effect of Si ions on the expressions of osteogenic genes in HG-treated hBMSCs

To assess the impact of Si ions on the osteogenesis of hBMSCs under HG condition, cells were cultured for 3 days in different medium. As shown in Fig. 2, the bone-related genes of hBMSCs showed a higher expression levels in the group NG + 15.92 ppm than that in NG alone group, suggesting that 15.92 ppm concentration of Si ions stimulated osteogenic differentiation of hBMSCs. Nevertheless, the bone-related gene expression levels in HG-treated hBMSCs were significantly lower than that in NG alone-treated cells, implying that HG suppressed the osteogenic differentiation of hBMSCs. Furthermore, the expression of osteogenesis-related markers was markedly higher in the hBMSCs cultured in HG medium containing 15.92 ppm Si ions (HG + 15.92) than the HG alone. The results show that reduction of expressions of osteogenic genes under HG condition was compensated by the Si ions treatment.

Figure 2.

Figure 2

Open in a new tab

Effects of HG and Si on expressions of the osteogenic differentiation biomarkers in hBMSCs. Quantitative PCR was performed for expression of the osteogenic differentiation biomarkers, including RUNX-2, BMP-2, ALP, COL-I and OCN in cultured hBMSCs under different conditions. The data are represented as mean ± S.D. *P < 0.05 and **P < 0.01 compared with NG control group. #P < 0.05 and ##P < 0.01 compared with HG group. NG, normal glucose; HG, high glucose; Si 15.92ppm represents the concentration of Si ions in medium

The effect of Si ions on ALP activity in HG-treated hBMSCs

The osteogenic differentiation of hBMSCs was evaluated in the presence of both HG and Si ions by performing the ALP activity assay and the ALP staining after seeding cells for 10 days. The results are shown in Fig. 3. Compared with NG alone, the ALP intensity was obviously higher in the cells cultured both in NG + 15.92 and in HG + 15.92 groups as compared with that in NG and HG groups (Fig. 3A). Quantitative ALP activity analysis showed similar results (Fig. 3B). The ALP activity of the cells cultured in HG was pointedly lower compared with cells cultured in NG alone. The ALP activity of cells in HG or NG with 15.92 ppm Si ions was higher compared with that in HG or NG alone, suggesting that suppression of ALP activity in HG-treated cells were compensated by Si ion treatment.

Figure 3.

Figure 3

Open in a new tab

Effects of HG and Si on the ALP activity of hBMSCs. About 10 days after culture, staining (A) and quantitative analysis (B) of ALP were performed. The data are represented as mean ± S.D. *P < 0.05 and **P < 0.01 compared with NG control group. #P < 0.05 compared with HG group. Scale bar = 100μm. NG, normal glucose; HG, high glucose; Si 15.92ppm represents the concentration of Si ions in medium

The effect of Si ions on mineralization in HG-treated hBMSCs

Alizarin red S staining was used to evaluated newly formed nodules after 21 days. As shown in Fig. 4, the staining intensity was weaker in the cells cultured in NG or HG alone medium, whereas a strong staining was observed in the cells cultured in NG and HG with 15.92 ppm Si ions. In addition, as compared with NG alone or NG + 15.92, the staining intensity in HG or HG + 15.92 treated cells was obviously weaker, separately.

Figure 4.

Figure 4

Open in a new tab

The formation of calcium nodules in cultured hBMSCs under different conditions. Calcium nodules were indicated by Alizarin red S staining in hBMSCs 21 days after culture. NG, normal glucose, 5.5mM; HG, high glucose, 30mM; 15.92 represents the concentration (15.92ppm) of Si ions in medium

Effects of Si ions on HG-mediated oxidative damage

To confirm whether Si ions compensate the oxidative damage induced by HG in hBMSCs, ROS level was detected by using the 2,7-Dichlorofluorescein （DCF） fluorescence staining. As shown in Fig. 5A, the level of the intracellular ROS was upgraded in HG group as compared with NG group. However, the intensity of ROS was clearly reduced in both 15.92 ppm Si ions treated cells as compared with that in HG or NG alone cultured cells.

Figure 5.

Figure 5

Open in a new tab

Effects of HG and Si on ROS level in hBMSCs. Staining (A) and quantitative measurement (B) of DCF fluorescence were performed in hBMSCs 24 hours after culture. The data are represented as mean ± S.D. *P < 0.05 and **P < 0.01 compared with NG control group. ##P < 0.01 compared with HG group; Scale bar = 75μm. NG, normal glucose; HG, high glucose; Si 15.92ppm represents the concentration of Si ions in medium

The quantitative measurement of DCF fluorescence was shown in Fig. 5B. The DCF values of hBMSCs were significantly higher in HG than NG indicating HG-induced oxidative damage in hBMSCs. However, the intensity of ROS was obviously reduced by the treatment of 15.92 Si ions as compared with NG or HG alone, suggesting that HG-induced oxidative damage in hBMSCs was alleviated by Si ions treatment.

BMP2 signaling pathway-related gene expression

To explore the regulatory role of BMP2 signaling in osteogenic differentiation induced by Si ions, hBMSCs were treated with 15.92 ppm Si ions in the presence of BMP2 signaling inhibitor noggin and under NG or HG condition for 3 days. The relative mRNA expression levels of BMP2 signaling pathway-related genes including BMP2 signaling receptors (BMPR1A, BMPR1B and BMPR2) and its downstream genes SMAD1, SMAD4 and SMAD5 were quantitated using qRT-PCR assay.

The results in Fig. 6 indicated that the mRNA levels of all target genes were noticeably upregulated by the treatment of 15.92 ppm Si ions as compared with NG or HG alone. More interestingly, Si ions induced increase of the expression of BMP2 signaling pathway genes was significantly attenuated by addition of noggin, suggesting that the activity of Si ions in promoting osteogenesis and compensating the HG effect on hBMSCs is closely related to activating BMP2 signaling pathway by stimulating some BMP receptors expression. Moreover, as shown in Fig. 7, the relative mRNA expression levels of BMP2 signaling pathway downstream genes such as RUNX2, ALP, COL1 and OCN were also decreased by noggin treatment in NG + 15.92 and HG + 15.92 groups. All the results indicate an association between BMP2 signaling and Si ion-induced osteogenic differentiation in hBMSCs cultured under HG condition.

Figure 6.

Figure 6

Open in a new tab

Effects of HG and Si on expression of BMP2-related signaling pathway genes in hBMSCs. hBMSCs were treated with BMP2 signaling inhibitor noggin and Si ions (15.92 ppm) under NG or HG condition for 3 days. qPCR was performed for expression of BMP2 signaling pathway genes BMPR1A, BMPR1B, BMPR2, SMAD1, SMAD4 and SMAD5. The data are represented as mean ± S.D. *P < 0.05 and **P < 0.01 compared with NG control group. #P < 0.05 and ##P < 0.01 compared with HG group. NG, normal glucose; HG, high glucose; Si 15.92ppm represents the concentration of Si ions in medium

Figure 7.

Figure 7

Open in a new tab

Effects of noggin on osteogenic marker genes in HG- and Si-treated hBMSCs. hBMSCs were treated with BMP2 signaling inhibitor noggin and Si ion (15.92ppm) under NG or HG condition for 3 days. qPCR was performed for expressions of osteogenic marker genes RUNX2, ALP, COL1 and OCN in hBMSCs. The data are represented as mean ± S.D. *P < 0.05, **P < 0.01, #P < 0.05, ##P < 0.01. NG, normal glucose; HG, high glucose; Si 15.92ppm represents the concentration of Si ions in medium

Ionic concentration

The concentrations of Ca and Si ions in media are shown in Table 2. We can see the concentration of Ca ions in different medium have no significant difference, on the contrary, the Si ions significantly higher than that in the NG or HG medium. Thus, the effect of Ca ions was not our concern in the current work.

Table 2.

Ions concentrations of the different medium (μg/ml)

NG NG + 2.59 NG + 15.92 HG HG + 2.59 HG + 15.92
Ca 70.01 70.14 70.79 70.01 70.14 70.79
Si 0 2.59a 15.92a 0 2.59a 15.92a
Open in a new tab

NG: normal glucose; HG: high glucose; 2.59 and 15.92 represent the concentration of Si ions.

aIndicates that the Si ion concentration in medium is significantly higher than that in NG or HG medium (P  <  0.01).

Discussion

Studies have shown that diabetes can affect bone metabolism through multiple pathways, and hyperglycemia has been demonstrated to cause delayed bone healing [3, 22–24]. hBMSCs governs multiple functions such as the self-renewal, hematopoiesis support, osteogenesis and immunity [25, 26]. Despite their application as seed cells for tissue engineering, early reports conveyed that HG could suppress the growth and osteogenic differentiation of hBMSCs [3, 4]. Moreover, BMSCs cultured in HG medium showed significant decrease of BMP2 gene expression, in which the activation of BMP signaling pathways was inhibited [6]. Biomaterials play a key role in the regulation of cell proliferation and differentiation of stem cells. In our previous work, we found that Si ions released from silicate bioceramics induce the cell growth and osteogenic differentiation of hBMSCs [9–12, 15]. However, the effect of Si ions on the growth and osteogenesis of hBMSCs under HG condition has not been reported. Therefore, we assumed that the Si ions from silicate bioceramics might compensate the HG-induced inhibition of the proliferation and osteogenic differentiation in hBMSCs. In the present study, we successfully confirmed that Si ions indeed have the activity to regulate osteogenic differentiation of hBMSCs not only under NG condition but also under HG condition, and inhibited the negative effect of HG through modulation of BMP2 signaling pathway.

BMP2 is a vital osteogenic marker and is generally expressed at early stage of osteogenic differentiation [27]. BMP2 and its receptor signaling pathway play a key role in the osteogenic differentiation [28, 29]. Previous study reported that BMP2 could affect the expression of Runx2 and Osterix [30]. BMP-SMAD signal pathway can regulate the whole process of osteoblast formation [31]. In vitro and animal experiments have demonstrated that inhibiting the BMP-SMAD pathway can significantly down-regulate the expression of Osterix and Runx2 [32, 33]. In addition, Runx2 interacts with SMAD1 and SMAD5 to enhance the expression of osteogenic genes [33]. Herein, we demonstrated that Si ions markedly stimulate the expression of Runx2, BMP2 receptors and SMADs, and the increased expression of these osteogenic markers was significantly reduced by noggin (Fig. 7), which suggests that the osteogenic differentiation of hBMSCs might be regulated via activation of BMP2 signaling pathway. The initiation of the canonical BMP signaling which play a significant role in the activation of target cells by BMPs is triggered by the association of BMP receptors (type I and type II) with BMPs followed by subsequent activation of the BMP-SMAD signaling [34, 35]. Thus, we supposed that the Si ions activated BMP2 signaling pathway possibly by stimulating the expression of BMP2 and BMP2 receptors. We found that the Si ions treatment increased the expression of the downstream genes of BMP2 signaling pathway such as SMAD1, SMAD4 and SMAD5 (Fig. 6). The complexes obtained by the association of SMAD1 and SMAD5 with SMAD4, are translocated into the nucleus where they act as transcription activators of target genes [34, 35], such as Runx2 responsible for bone formation and other genes associated with osteogenic differentiation ALP, COL1 and OCN [36]. These data further confirmed that Si ions stimulated the osteogenic differentiation of hBMSCs under HG condition via activation of BMP2 signaling pathway.

Oxidative stress is induced by elevated level of ROS that interrupts the reduction–oxidation (redox) balance in the cells [37]. Excessive production of ROS damages cell, and ROS is known to exert different functions in aging and its related complications [38]. Previous studies indicated that ROS production play a relevant role in mineral tissue homeostasis and is involved in bone remodeling via induction of bone resorption [39–44]. The data from in vitro studies showed that HG could increase the level of ROS in hBMSCs [4, 5]. Therefore, inhibition of ROS production may be one of the key steps for reducing cell damage induced by HG environment. Interestingly, our findings indicated that the treatment with Si ions pointedly lessened the production of ROS in hBMSCs (Fig. 5), which is the first report on the inhibition of ROS production by ions released from bioceramics.

Conclusion

In this work, we established that the inhibition of the proliferation and osteogenic differentiation of hBMSCs by HG environment was partially compensated by the treatment of Si ions released from CS bioceramics. Two possible mechanisms of the Si ions on the compensation of HG effect were proposed. On one side, Si ions stimulated osteogenic differentiation of hBMSCs under HG condition through activation of BMP2 signaling pathway. On the other side, Si ions inhibited ROS production of hBMSCs induced by HG treatment. Our findings suggested that the release of bioactive Si ions from silicate-based biomaterials reduces the cell damage caused by the HG environment, therefore, the silicate bioceramics might be used as hBMSCs carriers for bone tissue engineering applications in diabetic patients.

Funding

This work was supported by the Natural Science Foundation of China [Grant No. 31271054 and 31770980].

Conflict of interest statement. None declared.

References

  • 1. Hollinger J, Wong ME.. The integrated processes of hard tissue regeneration with special emphasis on fracture healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:594–606. [DOI] [PubMed] [Google Scholar]
  • 2. Jiang Y, Jahagirdar BN, Reinhardt RL. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41–9. [DOI] [PubMed] [Google Scholar]
  • 3. Chang TC, Hsu MF, Wu KK.. High glucose induces bone marrow-derived mesenchymal stem cell senescence by upregulating autophagy. PLoS One 2015;10:e0126537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Ying X, Chen X, Liu H. et al. Silibinin alleviates high glucose-suppressed osteogenic differentiation of human bone marrow stromal cells via antioxidant effect and PI3K/Akt signaling. Eur J Pharmacol 2015;765:394–401. [DOI] [PubMed] [Google Scholar]
  • 5. Dong K, Hao P, Xu S. et al. Alpha-lipoic acid alleviates high-glucose suppressed osteogenic differentiation of MC3T3-E1 cells via antioxidant effect and PI3K/Akt signaling pathway. Cell Physiol Biochem 2017;42:1897–906. [DOI] [PubMed] [Google Scholar]
  • 6. Wang J, Wang B, Li Y. et al. High glucose inhibits osteogenic differentiation through the BMP signaling pathway in bone mesenchymal stem cells in mice. EXCLI J 2013;12:584–97. [PMC free article] [PubMed] [Google Scholar]
  • 7. Chen Y, Hu Y, Yang L. et al. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3beta/beta-catenin pathway. Cell Biol Int 2017;41:822–32. [DOI] [PubMed] [Google Scholar]
  • 8. Stolzing A, Coleman N, Scutt A.. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res 2006;9:31–5. [DOI] [PubMed] [Google Scholar]
  • 9. Wu C, Chang J, Ni S. et al. In vitro bioactivity of akermanite ceramics. J Biomed Mater Res A 2006;76:73–80. [DOI] [PubMed] [Google Scholar]
  • 10. Wu C, Chang J, Zhai W. et al. Porous akermanite scaffolds for bone tissue engineering: preparation, characterization, and in vitro studies. J Biomed Mater Res B Res 2006;78:47–55. [DOI] [PubMed] [Google Scholar]
  • 11. Zhai W, Lu H, Chen L. et al. Silicate bioceramics induce angiogenesis during bone regeneration. Acta Biomater 2012;8:341–9. [DOI] [PubMed] [Google Scholar]
  • 12. Li H, Xue K, Kong N. et al. Silicate bioceramics enhanced vascularization and osteogenesis through stimulating interactions between endothelia cells and bone marrow stromal cells. Biomaterials 2014;35:3803–18. [DOI] [PubMed] [Google Scholar]
  • 13. Huang Y, Jin X, Zhang X. et al. In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials 2009;30:5041–8. [DOI] [PubMed] [Google Scholar]
  • 14. Zhai W, Lu H, Wu C. et al. Stimulatory effects of the ionic products from Ca-Mg-Si bioceramics on both osteogenesis and angiogenesis in vitro. Acta Biomater 2013;9:8004–14. [DOI] [PubMed] [Google Scholar]
  • 15. Xing M, Wang X, Wang E. et al. Bone tissue engineering strategy based on the synergistic effects of silicon and strontium ions. Acta Biomater 2018;72:381–95. [DOI] [PubMed] [Google Scholar]
  • 16. Li H, Zhai W, Chang J.. Effects of wollastonite on proliferation and differentiation of human bone marrow-derived stromal cells in PHBV/wollastonite composite scaffolds. J Biomater Appl 2009;24:231–46. [DOI] [PubMed] [Google Scholar]
  • 17. Xynos ID, Edgar AJ, Buttery LD. et al. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000;276:461–5. [DOI] [PubMed] [Google Scholar]
  • 18. Zhao C, Wang X, Gao L. et al. The role of the micro-pattern and nano-topography of hydroxyapatite bioceramics on stimulating osteogenic differentiation of mesenchymal stem cells. Acta Biomater 2018;73:509–21. [DOI] [PubMed] [Google Scholar]
  • 19. Han Y, Zeng Q, Li H. et al. The calcium silicate/alginate composite: preparation and evaluation of its behavior as bioactive injectable hydrogels. Acta Biomater 2013;9:9107–17. [DOI] [PubMed] [Google Scholar]
  • 20. Dong X, Li H, Zhou Y. et al. The stimulation of osteogenic differentiation of embryoid bodies from human induced pluripotent stem cells by akermanite bioceramics. J Mater Chem B 2016;4:2369–76. [DOI] [PubMed] [Google Scholar]
  • 21. Zhao C, Xia L, Zhai D. et al. Designing ordered micropatterned hydroxyapatite bioceramics to promote the growth and osteogenic differentiation of bone marrow stromal cells. J Mater Chem B 2015;3:968–76. [DOI] [PubMed] [Google Scholar]
  • 22. McCabe LR. Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 2007;102:1343–57. [DOI] [PubMed] [Google Scholar]
  • 23. Schwartz AV. Diabetes Mellitus: does it affect bone? Calcif Tissue Int 2003;73:515–9. [DOI] [PubMed] [Google Scholar]
  • 24. Beam HA, Parsons JR, Lin SS.. The effects of blood glucose control upon fracture healing in the BB Wistar rat with diabetes mellitus. J Orthop Res 2002;20:1210–6. [DOI] [PubMed] [Google Scholar]
  • 25. Chen M, Xu Y, Zhang T. et al. Mesenchymal stem cell sheets: a new cell-based strategy for bone repair and regeneration. Biotechnol Lett 2019;41:305. [DOI] [PubMed] [Google Scholar]
  • 26. Ohara N, Hayashi Y, Yamada S. et al. Early gene expression analyzed by cDNA microarray and RT-PCR in osteoblasts cultured with water-soluble and low molecular chitooligosaccharide. Biomaterials 2004;25:1749–54. [DOI] [PubMed] [Google Scholar]
  • 27. Young DW, Pratap J, Javed A. et al. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation. J Cell Biochem 2005;94:720–30. [DOI] [PubMed] [Google Scholar]
  • 28. Li X, Cao X.. BMP signaling and skeletogenesis. Ann NY Acad Sci 2006;1068:26–40. [DOI] [PubMed] [Google Scholar]
  • 29. Yamaguchi A, Ishizuya T, Kintou N. et al. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 1996;220:366–71. [DOI] [PubMed] [Google Scholar]
  • 30. Zaidi M. Skeletal remodeling in health and disease. Nat Med 2007;13:791–801. [DOI] [PubMed] [Google Scholar]
  • 31. Cao X, Chen D.. The BMP signaling and in vivo bone formation. Gene 2005;357:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Yoo SH, Kim JG, Kim BS. et al. BST2 mediates osteoblast differentiation via the BMP2 signaling pathway in human alveolar-derived bone marrow stromal cells. PLoS One 2016;11:e0158481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Lee MH, Kwon TG, Park HS. et al. BMP-2-induced osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 2003;309:689–94. [DOI] [PubMed] [Google Scholar]
  • 34. Derynck R, Zhang YE.. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425:577–84. [DOI] [PubMed] [Google Scholar]
  • 35. Rosen V. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev 2009;20:475–80. [DOI] [PubMed] [Google Scholar]
  • 36. Kim BS, Kim HJ, Kim JS. et al. IFITM1 increases osteogenesis through Runx2 in human alveolar-derived bone marrow stromal cells. Bone 2012;51:506–14. [DOI] [PubMed] [Google Scholar]
  • 37. Wauquier F, Leotoing L, Coxam V. et al. Oxidative stress in bone remodelling and disease. Trends Mol Med 2009;15:468–77. [DOI] [PubMed] [Google Scholar]
  • 38. Krause KH. Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases. Exp Gerontol 2007;42:256–62. [DOI] [PubMed] [Google Scholar]
  • 39. Bai XC, Lu D, Liu AL. et al. Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast. J Biol Chem 2005;280:17497–506. [DOI] [PubMed] [Google Scholar]
  • 40. Ha H, Kwak HB, Lee SW. et al. Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res 2004;301:119–27. [DOI] [PubMed] [Google Scholar]
  • 41. Koh JM, Lee YS, Kim YS. et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 2006;21:1003–11. [DOI] [PubMed] [Google Scholar]
  • 42. Lee NK, Choi YG, Baik JY. et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005;106:852–9. [DOI] [PubMed] [Google Scholar]
  • 43. Wittrant Y, Gorin Y, Woodruff K. et al. High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone 2008;42:1122–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Garrett IR, Boyce BF, Oreffo RO. et al. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990;85:632–9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Regenerative Biomaterials are provided here courtesy of Oxford University Press

RESOURCES